This site is intended for health professionals only
Wednesday 22 October 2014
Share |

Assay identifies lethal Clostridium difficile pathogen

LATEST NEWS
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has announced that it obtained CE Marking of the BD MAX™ Cdiff Assay. The assay detects the toxin B gene (tcdB), which has been shown to be present in all toxigenic C. difficile and is essential for disease.
 
Run on the fully automated BD MAX™ System, the assay is designed to rapidly and accurately identify patients with Clostridium difficile infection (CDI), including those caused by hypervirulent strains.

Ads by Google